Patricia Carr, SVP, Chief Accounting Officer at Jazz Pharmaceuticals plc (JAZZ), sold 2,723 shares at $182.94 ($504K) on 2026-03-09, disclosed to the SEC on 2026-03-09.
Seasonal sale ($504k) by SVP, Chief Accounting Officer — this insider has traded JAZZ in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $186.77 | 1,436 | $268K | 53.3% |
| 2 | $182.94 | 1,287 | $235K | 46.7% |
| Total | $184.96 avg | 2,723 | $504K | 100% |
| Filing → |
| JAZZ | SELL | 2025-11-20 | $1.9M | — | Filing → |
| JAZZ | SELL | 2025-03-11 | $314K | — | Filing → |
| JAZZ | SELL | 2025-03-03 | $917K | — | Filing → |